Analgesics. Opioids, adjuvants, and others
Matthew, M.T.; Nance, P.W.
Physical Medicine and Rehabilitation Clinics of North America 10(2): 255-273 Vii
1999
ISSN/ISBN: 1047-9651 PMID: 10370931 Document Number: 500533
The purpose of this article is to summarize the main categories of pain-relieving medications. The authors review a number of analgesic preparations and treatments, with special emphasis on advantages, precautions, limitations, and various routes of administration.
Document emailed within 1 workday
Related Documents
Woolf, C.J.; Hashmi, M. 2004: Use and abuse of opioid analgesics: potential methods to prevent and deter non-medical consumption of prescription opioids Current Opinion in Investigational Drugs 5(1): 61-66Malec, D.; Grabowska, E.; Langwiński, R. 1978: Central action of narcotic analgesics. Part IV. Noradrenergic influences on the activity of analgesics in rats Polish Journal of Pharmacology and Pharmacy 30(5): 627-637
Kaneto, H.; Watanabe, J. 1980: Tolerance to and dependence on opioids in isolated longitudinal muscle of guinea pig ileum. Validity of the muscle preparation as a receptor model for opioids Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 76(5): 347-354
Malec, D.; Langwiński, R. 1981: Central action of narcotic analgesics. VIII. the effect of dopaminergic stimulants on the action of analgesics in rats Polish Journal of Pharmacology and Pharmacy 33(3): 273-282
Malec, D.; Fidecka, S.; Langwiński, R. 1977: Central action of narcotic analgesics. I. Catalepsy and stereotypy in rats and narcotic analgesics Polish Journal of Pharmacology and Pharmacy 29(3): 177-193
Kensil, C.R.; Wu, J.Y.; Anderson, C.A.; Wheeler, D.A.; Amsden, J. 1998: QS-21 and QS-7: purified saponin adjuvants Developments in Biological Standardization 92: 41-47
Behling, U.H.; Campbell, B.; Chang, C.M.; Rumpf, C.; Nowotny, A. 1976: Synthetic glycolipid adjuvants Journal of Immunology 117(3): 847-851
Paraf, A. 1970: Mechanism of action of immunological adjuvants Annales de l'Institut Pasteur 118(4): 419-441
Garba, S.A.; Terry, R.J.; Adegboye, D.S.; Lamorde, A.G.; Abalaka, J.A. 1989: The choice of adjuvants in Mycoplasma vaccines Microbios 57(230): 15-19
Keipert, S.; Becker, J.; Schultze, H.H.; Voigt, R. 1973: Correlations between macromolecular adjuvants and drugs Die Pharmazie 28(3): 145-183
Portoles, A.; Ureña, T.P.; Ramos, F.; Lopez, R.; Espinosa, M. 1975: Penicillin immunogenicity in the presence of different pharmaceutical adjuvants International Journal of Clinical Pharmacology and Biopharmacy 11(1): 7-9
Popescu, C.; Durbaca, S.; Ivanov, D. 1998: Liposomes as immunological adjuvants for tetanus vaccine Roumanian Archives of Microbiology and Immunology 57(3-4): 263-269
Shoenfeld, Y.; Agmon-Levin, N. 2012: Autoimmune or autoinflammatory syndromes induced by adjuvants Harefuah 151(1): 9-11
Bravi, S. 2004: The ATAC study on adjuvants in breast cancer I Suppli di Tumori: Official Journal of Societa Italiana di Cancerologia . 3(4): S15
Murray, R.; Cohen, P.; Hardegree, M.C. 1972: Mineral oil adjuvants: biological and chemical studies Annals of Allergy 30(3): 146-151
Harandi, A.M.; Sanchez, J.; Eriksson, K.; Holmgren, J. 2003: Recent developments in mucosal immunomodulatory adjuvants Current Opinion in Investigational Drugs 4(2): 156-161
Behbehani, K.; Beller, D.I.; Unanue, E.R. 1985: The effects of beryllium and other adjuvants on Ia expression by macrophages Journal of Immunology 134(4): 2047-2049
Nishimura, N.; Mori, Y.; Kusumoto, H.; Kamekawa, R.; Iino, A. 1972: Clinical studies on anesthetic adjuvants. II. Effects of CRD-401 on hemodynamics Masui. Japanese Journal of Anesthesiology 21(11): 1147-1151
Nakano, Y.; Nakano, K. 1975: Development of delayed hypersensitivity in mice and the effect of adjuvants Nihon Saikingaku Zasshi. Japanese Journal of Bacteriology 30(1): 218
Stampf 1978: In vitro studies on the interactions between active ingredients and adjuvants Die Pharmazie 33(7): 447-450